Startups
AesculaTech uses a new class of smart materials to develop biomedical and consumer products that are engineered to be adaptable and responsive
Investors 2
| Date | Name | Website |
| Sign up to see | Sign up to see | Sign up to see |
| MBC BioLabs | mbcbiolabs.com |
Mentions in press and media 2
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Mar 19, 2018 | Biomedical startup AesculaTech is creating a new, more patient-friendly drug delivery system | “Reverse chocolate” — that’s how AesculaTech co-founder and chief science officer Niki Bayat describes the material created by its proprietary technology. Chocolate is solid until heated, when it melts deliciously into liquid. AesculaTech’s... |
Reviews 0
FAQ about AesculaTech
Who has invested in AesculaTech?
Parsers VC lists 2 investors of AesculaTech, among them MBC BioLabs.
What has the press written about AesculaTech?
Parsers VC has collected 2 articles mentioning AesculaTech, among them “Biomedical startup AesculaTech is creating a new, more patient-friendly drug delivery system” (Mar 19, 2018).
Is AesculaTech still active?
Yes, AesculaTech is active; its latest activity on Parsers VC dates from Mar 19, 2018.